Interacting Drugs |
Hyoscyamine, atropine, scopolamine, and phenobarbital vs Tolvaptan |
Security Level |
 |
Mechanism |
Tolvaptan: CYP3A4 Inducers (Strong) may decrease the serum concentration of Tolvaptan. |
Management |
If concurrent use is necessary, increased doses of tolvaptan (with close monitoring for toxicity and clinical response) may be needed. |
Hyoscyamine, atropine, scopolamine, and phenobarbital vs Tolvaptan
Post Review about Hyoscyamine, atropine, scopolamine, and phenobarbital vs Tolvaptan Click here to cancel reply.
Other Interactions of Hyoscyamine, atropine, scopolamine, and phenobarbital
Other Interactions of Tolvaptan
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.